[go: up one dir, main page]

WO2011077455A3 - Development of an effective herbal drug formulation for the treatment of sickle cell disease and the process thereof - Google Patents

Development of an effective herbal drug formulation for the treatment of sickle cell disease and the process thereof Download PDF

Info

Publication number
WO2011077455A3
WO2011077455A3 PCT/IN2010/000840 IN2010000840W WO2011077455A3 WO 2011077455 A3 WO2011077455 A3 WO 2011077455A3 IN 2010000840 W IN2010000840 W IN 2010000840W WO 2011077455 A3 WO2011077455 A3 WO 2011077455A3
Authority
WO
WIPO (PCT)
Prior art keywords
treatment
sickle cell
cell disease
development
drug formulation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/IN2010/000840
Other languages
French (fr)
Other versions
WO2011077455A2 (en
Inventor
Vinod Domaji Rangari
Virendra Sukhadeo Borkar
Anwar Siraj Daud
Showkat Ahmad Patni
Jayant Janrao Thakre
Milind Pandurang Mane
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
UNIJULES LIFE SCIENCES Ltd
Original Assignee
UNIJULES LIFE SCIENCES Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by UNIJULES LIFE SCIENCES Ltd filed Critical UNIJULES LIFE SCIENCES Ltd
Publication of WO2011077455A2 publication Critical patent/WO2011077455A2/en
Publication of WO2011077455A3 publication Critical patent/WO2011077455A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/24—Apocynaceae (Dogbane family), e.g. plumeria or periwinkle
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The invention comprises a pharmaceutical dosage composition comprising antisickling effective amount of extract of seeds of Wrightia tinctoria R. Br. with or without combination with extract of raw fruits of Carica papaya L, process of making the same and its use for treatment of Sickle Cell Disease.
PCT/IN2010/000840 2009-12-22 2010-12-22 Development of an effective herbal drug formulation for the treatment of sickle cell disease and the process thereof Ceased WO2011077455A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN2948/MUM/2009 2009-12-22
IN2948MU2009 2009-12-22

Publications (2)

Publication Number Publication Date
WO2011077455A2 WO2011077455A2 (en) 2011-06-30
WO2011077455A3 true WO2011077455A3 (en) 2011-08-11

Family

ID=44196222

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IN2010/000840 Ceased WO2011077455A2 (en) 2009-12-22 2010-12-22 Development of an effective herbal drug formulation for the treatment of sickle cell disease and the process thereof

Country Status (1)

Country Link
WO (1) WO2011077455A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108686196A (en) * 2018-08-21 2018-10-23 叶文文 Children answer gas soup, its formula and preparation method

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009084032A2 (en) * 2007-12-03 2009-07-09 Vedic Elements Private Limited Stable hydrophobic topical herbal formulation

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009084032A2 (en) * 2007-12-03 2009-07-09 Vedic Elements Private Limited Stable hydrophobic topical herbal formulation

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
AHMAD, I.: "Oleochemicals from.Isoricinoleic Acid (Wrightia tinctoria Seed Oil)", INDUSTRIAL AND ENGINEERING CHEMISTRY RESEARCH, vol. 47, no. 6, 2008, pages 2091 - 2095, XP002697405, DOI: doi:10.1021/ie070761b *
AKIHISA, T ET AL.: "14a-Methylzymosterol and other Sterols from Wrightia tinctoria Seeds", PHYTOCHEMISTRY, vol. 27, no. 10, 1988, pages 3231 - 3234 *
JOLLY, C ET AL.: "Comparative Pharmacognostical, Physicochemical And Antibacterial Studies On Seeds Of Holarrhena Antidysenterica Wall And Wrightia Tinctoria R.Br.", INDIAN JOURNAL OF PHARMACEUTICAL SCIENCES, vol. 58, no. 2, 1996, pages 51 - 54 *
MOJISOLA, O ET AL.: "Antisickling Properties of Carica papaya Linn.", JOURNAL OF NATURAL PRODUCTS, vol. 1, 2008, pages 56 - 66 *
OUDHIA, P.: "Medicinal Herbs of Chhattisgarh, India having less known Traditional Uses. II. Indrajau (Wrightia tinctoria, Family : Apocynaceae)", 16 November 2006 (2006-11-16), Retrieved from the Internet <URL:http://web.archive.org/web/2006111683344/http://botanical.com/site/column_poudhia/155_indrajau.html> [retrieved on 20110525] *
RAMCHANDRA, P ET AL.: "Wrightial, a New Terpene from Wrightia Tinctoria", JOURNAL OF NATURAL PRODUCTS, vol. 56, no. 10, 1993, pages 1811 - 1812 *

Also Published As

Publication number Publication date
WO2011077455A2 (en) 2011-06-30

Similar Documents

Publication Publication Date Title
BRPI0924460A2 (en) pharmaceutical composition for use in medical and veterinary ophthalmology
WO2011018501A3 (en) Composition including an unsaponifiable fraction
WO2011026125A3 (en) Gastric retentive pharmaceutical compositions for immediate and extended release of acetaminophen
AP2011005780A0 (en) Pharmaceutical composition comprising glucopyranosyl diphenylmethane derivatives, pharmaceutical dosage form thereof, process for their preparation and uses thereof for improved glycemic control in a patient.
WO2009153496A3 (en) Ppar agonist compounds and preparation and uses thereof for treating diabetes and/or dyslipidemia
WO2010127205A3 (en) Fixed dose drug combination formulations
IL211842A (en) Antibody or human tgfbrii-binding fragment thereof, pharmaceutical compositions comprising them and use thereof in the manufacture of medicaments for inhibiting angiogenesis
WO2010066749A3 (en) Ulipristal acetate tablets
WO2007093880A3 (en) Novel pyrone-indole derivatives and process for their preparation
WO2012070890A3 (en) Pharmaceutical composition comprising extract of lonicera japonica for prevention and treatment of gastroesophageal reflux disease
WO2006138608A3 (en) Pharmaceutical compositions and use thereof
WO2009068708A8 (en) Pharmaceutical composition with prolonged release of somatostatin or an analogue thereof
WO2011072069A3 (en) Gastric retentive pharmaceutical compositions for extended release of polypeptides
WO2012050398A3 (en) Pharmaceutical composition including herbal medicine extract for preventing or treating lung cancer
WO2013175504A3 (en) Herbal composition for vaginal treatment
WO2011043631A3 (en) Pharmaceutical composition for preventing and treating cold, containing reynoutria elliptica extract, fraction thereof or stilbene-based compound
WO2012050397A3 (en) Pharmaceutical composition including herbal medicine extract for preventing or treating kidney cancer
IL210386A (en) Indole derivatives, pharmaceutical compositions comprising same and use thereof for preparing medicaments for the treatment or prevention of neurodegenerative diseases
UY31662A1 (en) COMPOSITIONS OF RANITIDINE TABLETS OF ORAL DISINTEGRATION AND ITS METHODS OF ELABORATION.
WO2009053628A3 (en) Novel compounds, preparation and uses thereof
WO2012040082A3 (en) Antidiabetic solid pharmaceutical compositions
GB2493898A (en) A novel herbal formulation for the prevention and management of type-2 diabetes mellitus and vascular complications associated with diabetes
WO2011055931A3 (en) Composition for preventing or treating diseases caused by influenza viruses
WO2011113000A8 (en) Novel ester containing compositions and methods
WO2010090611A3 (en) Taste and odor masked pharmaceutical compositions with high bioavailability

Legal Events

Date Code Title Description
NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 10838837

Country of ref document: EP

Kind code of ref document: A2